Showing results (1-10 of 196) with videos related to
Sort By:
Pageof 20
Nederlands Tijdschrift Voor Geneeskunde|April 29, 1998
[Hormone replacement therapy following breast carcinoma]J G Klijn, M BontenbalCancer Treatment Reviews|April 1, 1993
Cell biological factors associated with the response of breast cancer to systemic treatmentJ G Klijn, E M Berns, M Bontenbal, et al.European Journal of Cancer & Clinical Oncology|September 1, 1988
Oestradiol enhances doxorubicin uptake and cytotoxicity in human breast cancer cells (MCF-7)M Bontenbal, P Sonneveld, J A Foekens, et al.Nederlands Tijdschrift Voor Geneeskunde|October 9, 1998
[Chemotherapy in metastasized breast carcinoma]M Bontenbal, R de Wit, J G Klijn, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1996
Novel endocrine therapies in breast cancerJ G Klijn, B Setyono-Han, M Bontenbal, et al.The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
Clinical breast cancer, new developments in selection and endocrine treatment of patientsJ G Klijn, P M Berns, M Bontenbal, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 20, 1990
Manipulation of cell cycle kinetics: influence on the cytotoxicity of doxorubicin in human breast cancer cellsM Bontenbal, A M Sieuwerts, H A Peters, et al.Breast Cancer Research and Treatment|May 1, 1995
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancerM Bontenbal, A S Planting, J Verweij, et al.Breast Cancer Research and Treatment|January 8, 1999
Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitroM Bontenbal, A M Sieuwerts, H A Peters, et al.Cancer Research|November 1, 1992
Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patientsJ A Foekens, M Schmitt, W L van Putten, et al.Pageof 20